JAMBOREX Trademark

Trademark Overview

On Thursday, January 15, 2009, a trademark application was filed for JAMBOREX with the United States Patent and Trademark Office. The USPTO has given the JAMBOREX trademark a serial number of 77650531. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 11, 2019. This trademark is owned by Glaxo Group Limited. The JAMBOREX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
jamborex

General Information

Serial Number77650531
Word MarkJAMBOREX
Filing DateThursday, January 15, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 11, 2019
Registration Number4296728
Registration DateTuesday, March 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe wording "JAMBOREX" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, October 11, 2019CANCELLED SEC. 8 (6-YR)
Monday, March 5, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 5, 2013REGISTERED-PRINCIPAL REGISTER
Friday, January 25, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, January 24, 2013NOTICE OF ALLOWANCE CANCELLED
Thursday, January 24, 2013TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, August 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 6, 2012EXTENSION 5 GRANTED
Monday, July 30, 2012EXTENSION 5 FILED
Monday, July 30, 2012TEAS EXTENSION RECEIVED
Saturday, January 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 20, 2012EXTENSION 4 GRANTED
Wednesday, January 18, 2012EXTENSION 4 FILED
Wednesday, January 18, 2012TEAS EXTENSION RECEIVED
Friday, August 5, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 4, 2011EXTENSION 3 GRANTED
Tuesday, July 19, 2011EXTENSION 3 FILED
Tuesday, July 19, 2011TEAS EXTENSION RECEIVED
Thursday, January 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2011EXTENSION 2 GRANTED
Thursday, December 16, 2010EXTENSION 2 FILED
Thursday, December 16, 2010TEAS EXTENSION RECEIVED
Friday, August 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2010EXTENSION 1 GRANTED
Thursday, July 8, 2010EXTENSION 1 FILED
Thursday, August 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 8, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 7, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 7, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 11, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 10, 2009ASSIGNED TO LIE
Wednesday, September 9, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 27, 2009NON-FINAL ACTION E-MAILED
Friday, March 27, 2009NON-FINAL ACTION WRITTEN
Friday, March 27, 2009ASSIGNED TO EXAMINER
Wednesday, January 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

jamborex pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic